The nuclear receptor PPARgamma is a master regulator of adipogenesis. Activation of this transcription factor via natural and synthetic agonists leads to the induction of genes involved in fat differentiation and insulin sensitization. Although the mechanisms of PPARgamma's ligand-dependent transcriptional activation have been studied extensively since the discovery of this factor in the early nineties, the ligand-independent function of PPARgamma has not yet been fully elucidated. One of the main projects in the lab is the identification of novel molecules and pathways that can modulate PPARgamma's ligand-independent activity. ? ? In order to identify novel PPARgamma modulators we have taken the following approaches: ? ? 1)We have analyzed several cofactors candidates that appear to be expressed during adipocyte differentiation and assessed their ability to function as potential transcriptional cofactors for PPARgamma;? ? 2)We have generated several PPARgamma-GST fusion constructs that express distinct domains of PPARgamma. These fusion proteins produced in bacteria have been utilized in biochemical assays to purify potential novel N-terminal interactors. Nuclear extracts obtained from preadipocytes and fully differentiated adipocytes have been analyzed and novel interacting proteins have been identified by mass spectrometry. ? ? We are currently confirming that these factors interact directly with PPARgamma and that they can modulate PPARgamma's transcriptional activity and adipogenic function, both in vitro and in vivo.? ? In addition to the characterization of novel PPARgamma interacting molecules, we are interested in defining novel signaling pathways that can modify adipogenesis.? ? For this purpose we have analyzed the pattern of expression of several kinases during different phases of fat differentiation and have identified several potential kinases that could be involved in the regulation of the adipogenic process. ? ? We are currently performing gain-of-function experiments in preadipocytes to assess the ability of these kinases to modulate fat differentiation. In addition we are testing the role of these kinases in vivo, via loss-of-function experiments carried out specifically in adipose tissue.
| Markitsis, Anastasios; Lai, Yinglei (2010) A censored beta mixture model for the estimation of the proportion of non-differentially expressed genes. Bioinformatics 26:640-6 |
| Drori, Stavit; Girnun, Geoffrey D; Tou, Liqiang et al. (2005) Hic-5 regulates an epithelial program mediated by PPARgamma. Genes Dev 19:362-75 |
| Hong, Jeong-Ho; Hwang, Eun Sook; McManus, Michael T et al. (2005) TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 309:1074-8 |
